Fundraising FoxLucius Partners — Full Portfolio
4 tracked investments · listed companies and verified rows first
Adapt Biotechnologies develops the BRiTE platform, a bispecific antibody technology designed to treat brain tumors and intracerebral malignancies by activating T cells to target and destroy glioma cells.
BiotechDeep TechHealthtechMedical DevicesCharlotte, US
Michael J. Roberts(Chief Executive Officer and Director)inL. Arthur Hewitt(Chief Development Officer)Simon Pedder(Executive Chairman)Timothy L. Maness(Chief Financial Officer)
BoardAnthony Zook(Director)J. Nick Riehle(Director)
Shine AyG is a skin care studio offering eyebrow design services, including microblading, and premium skincare treatments.
ConsumerWellness & FitnessBoca Raton, US
Jane Gottschalk(President, Chief Creative Officer and Director)inChath Weerasinghe(Chief Financial Officer and Chief Operating Officer)inMark N. Tompkins(Director)Ian Jacobs(Executive Officer, Director)
Co-investorsVedra Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.